Phospho-PRKD1 (Tyr463) Antibody

What is PRKD1 and what role does Tyr463 phosphorylation play in its function?

PRKD1 (Protein Kinase D1), also known as PKC-mu, PKCM, or PKD, is a serine/threonine protein kinase that functions in many extracellular receptor-mediated signal transduction pathways . It has a subcellular location in both the cytoplasm and cell membrane .

Tyrosine 463 phosphorylation is a critical regulatory event in PRKD1 activation. Specifically, Tyr463 phosphorylation induces a conformational change that allows subsequent Src-mediated phosphorylation of Tyr95 in the N-terminus of PKD1 . This phosphorylation at Tyr95 creates a docking site for the C2 domain of PKCδ, which then phosphorylates PKD1 at its activation loop Ser738/742 residues, events essential for PKD1 activation under oxidative stress conditions .

What applications are Phospho-PRKD1 (Tyr463) antibodies suitable for?

Phospho-PRKD1 (Tyr463) antibodies are validated for multiple research applications, including:

• Western Blot (WB): Typically used at dilutions of 1:300-5000 or 1:500-2000, depending on the specific antibody preparation

• Immunohistochemistry (IHC): Both paraffin-embedded (IHC-P) and frozen sections (IHC-F) at dilutions of 1:50-200

• Immunofluorescence (IF): Recommended dilutions of 1:50-200 for cellular immunofluorescence studies

• ELISA: Generally used at higher dilutions (1:40000) for enhanced sensitivity

The specific dilution requirements may vary between manufacturers, so consulting the product datasheet for optimization is recommended for each experimental system.

What are the available conjugation options for Phospho-PRKD1 (Tyr463) antibodies?

Phospho-PRKD1 (Tyr463) antibodies are available in various conjugated forms to support different experimental needs:

• Unconjugated antibodies: Standard format for maximum flexibility, typically used with secondary antibody detection systems

• Fluorophore-conjugated antibodies:

  • AbBy Fluor® 488 Conjugated: For green fluorescence detection

  • Cy3 Conjugated: For red fluorescence detection in immunofluorescence applications

These conjugation options allow researchers to design multi-color immunostaining experiments and reduce the need for secondary antibody incubation steps in certain applications.

How should Phospho-PRKD1 (Tyr463) antibodies be stored and handled?

Optimal storage and handling recommendations for Phospho-PRKD1 (Tyr463) antibodies include:

• Storage temperature: Store at -20°C for maximum stability

• Buffer formulation: Typically supplied in phosphate buffered saline (pH 7.4) containing stabilizers such as:

  • 50% glycerol to prevent freeze-thaw damage

  • 0.02% sodium azide as a preservative

  • 1% BSA or similar protein to maintain antibody stability

• Aliquoting: Divide into multiple small aliquots to avoid repeated freeze-thaw cycles, which can degrade antibody performance

• Long-term storage: Can be stored for up to 1 year from date of receipt when properly maintained at -20°C

What is the typical immunogen used to generate Phospho-PRKD1 (Tyr463) antibodies?

Most commercial Phospho-PRKD1 (Tyr463) antibodies are generated using similar immunization strategies:

• Immunogen composition: Synthetic phosphopeptides derived from the region surrounding phosphorylated Tyrosine 463 of human PRKD1

• Host animal: Primarily produced in rabbits for polyclonal antibodies

• Carrier protein: Typically conjugated to KLH (Keyhole Limpet Hemocyanin) to enhance immunogenicity

• Peptide sequence: Often based on amino acids 429-478 of human PRKD1, containing the phosphorylated Tyr463 site

• Example sequence motif: R-Y-Y(p)-K-E derived from the region surrounding the phosphorylation site

How does the mechanism of PRKD1 Tyr463 phosphorylation compare to phosphorylation events in other PRKD isoforms?

The mechanism of tyrosine phosphorylation differs between PRKD isoforms in important ways:

• PRKD1 (PKD1): In the canonical activation model, Tyr463 phosphorylation is the first step that enables subsequent Src-mediated phosphorylation of Tyr95, creating a docking site for PKCδ, which then phosphorylates the activation loop serines (Ser738/742)

• PRKD2: Research indicates differences in the interdependence of tyrosine phosphorylation sites:

  Phosphorylation Site	Relationship in PRKD2
  Tyr438 (PRKD2 equivalent to Tyr463 in PRKD1)	Tyr717 phosphorylation is only partly dependent on Tyr438 phosphorylation
  Ser706/710 (activation loop)	Strong dependency observed - phosphomimetic S706/710E mutations increased Tyr717 phosphorylation ~4-fold, while S706/710A mutations completely abolished Tyr717 phosphorylation

These findings suggest that while PRKD1 and PRKD2 share structural similarities, their regulatory mechanisms exhibit important distinctions, particularly in the sequence and interdependence of phosphorylation events .

What controls and validation methods should be employed when using Phospho-PRKD1 (Tyr463) antibodies?

Rigorous validation of Phospho-PRKD1 (Tyr463) antibodies is essential for reliable research outcomes:

Recommended controls:

• Positive controls: Cell lines or tissues known to express phosphorylated PRKD1 (e.g., cells treated with H₂O₂ to induce oxidative stress)

• Negative controls:

  • Non-phosphorylated PRKD1 samples

  • Samples treated with phosphatase

  • Y463F mutant PRKD1 expressing cells (tyrosine to phenylalanine mutation prevents phosphorylation)

Validation methods:

• Phosphopeptide competition assays: Pre-incubation of antibody with the phosphopeptide immunogen should block specific binding

• Phospho-specific purification: Many antibodies are purified using affinity chromatography with phospho-specific peptides, with non-phospho specific antibodies removed through non-phosphopeptide chromatography

• Western blot analysis: To confirm specific recognition of the phosphorylated form versus total PRKD1

• Mutant protein analysis: Testing antibody reactivity against Y463F mutants to confirm specificity for the phosphorylated residue

How do PRKD1 Tyr463 phosphorylation levels respond to various cellular stimuli and stress conditions?

PRKD1 Tyr463 phosphorylation is regulated by specific cellular conditions:

Oxidative stress response:

• H₂O₂ treatment induces a well-characterized oxidative stress response that promotes PRKD1 Tyr463 phosphorylation

• Under oxidative stress, phosphorylation at Tyr463 occurs via SRC-ABL1 and contributes to cell survival by activating the IKK complex

• This activation leads to subsequent nuclear translocation and activation of NFKB1

Experimental induction:

• Oxidative stress agents (H₂O₂, menadione)

• Growth factors (including VEGF in endothelial cells)

• PKC activators (phorbol esters)

Methodological considerations:

• Cell type-specific differences exist in basal and stimulated phosphorylation levels

• The kinetics of phosphorylation should be carefully determined as the response may be transient

• When designing experiments to measure phosphorylation changes, appropriate time points (often 5-30 minutes post-stimulation) should be included

What is the relationship between PRKD1 Tyr463 phosphorylation and downstream NF-κB pathway activation?

PRKD1 Tyr463 phosphorylation plays a crucial role in activating NF-κB signaling, particularly under oxidative stress conditions:

• Sequential activation mechanism:

  • Oxidative stress induces Tyr463 phosphorylation of PRKD1 via SRC-ABL1

  • This enables subsequent phosphorylation events including activation loop serines

  • Activated PRKD1 stimulates the IKK complex

  • IKK activation promotes nuclear translocation and transcriptional activity of NF-κB

• Functional outcomes:

  • Transcriptional activation of NF-κB target genes, including MnSOD

  • Enhanced cellular detoxification from damaging reactive oxygen species

  • Promotion of cell survival pathways under stress conditions

While PRKD1 clearly activates the NF-κB pathway via the IKK complex, the search results note that "a direct target of PKD1 in this pathway remains elusive" , indicating a need for further research to fully elucidate the precise molecular intermediates in this signaling cascade.

How can Phospho-PRKD1 (Tyr463) antibodies be effectively used in cell-based assays?

For optimal use of Phospho-PRKD1 (Tyr463) antibodies in cell-based assays:

Cell-Based ELISA applications:

• Specialized kits like the PKD1/PKC mu (Phospho-Tyr463) Colorimetric Cell-Based ELISA Kit offer lysate-free approaches to measure phosphorylation directly in cultured cells

• These assays can detect relative amounts of phosphorylated PRKD1 and are useful for:

  • Measuring effects of various treatments

  • Evaluating inhibitor effects (siRNA or chemicals)

  • High-throughput screening applications

Immunofluorescence optimization:

• Cell fixation: 4% paraformaldehyde typically preserves phospho-epitopes well

• Permeabilization: 0.1-0.3% Triton X-100 allows antibody access while maintaining cellular architecture

• Blocking: BSA-containing buffers (1-5%) reduce background

• Antibody dilution: Start with manufacturer's recommendation (typically 1:50-200 for IF applications)

• Counterstaining: Nuclear stains (DAPI) and cytoskeletal markers provide context for phospho-PRKD1 localization

Confocal microscopy considerations:

• Conjugated antibodies (Cy3, AbBy Fluor® 488) enable direct detection without secondary antibodies

• Co-staining with total PRKD1 antibodies (using distinct fluorophores) can provide phosphorylation/total protein ratios

• Z-stack imaging may be necessary to fully capture PRKD1 distribution between membrane and cytoplasmic compartments

What methodological approaches are recommended for studying PRKD1 inhibition using Phospho-PRKD1 (Tyr463) antibodies?

When investigating PRKD1 inhibition, researchers can employ Phospho-PRKD1 (Tyr463) antibodies through several approaches:

Chemical inhibitor studies:

• Novel inhibitors like pyrazine benzamide PKD inhibitor CRT5 have been characterized for their effects on PRKD1/2 activity

• Inhibitor effectiveness can be monitored by measuring changes in Tyr463 phosphorylation levels

• Dose-response experiments should include determination of:

  • Biochemical IC₅₀ values (CRT5 shows values of 1-2 nM for PKD isoforms)

  • Cellular cytotoxicity (LD₅₀) to distinguish specific inhibition from general toxicity

Experimental design recommendations:

• Time-course experiments: Determine optimal time points for measuring inhibition effects

• Concentration gradients: Use multiple inhibitor concentrations to generate dose-response curves

• Positive controls: Include known PRKD1 activators (oxidative stress, growth factors) to confirm inhibition of stimulated phosphorylation

• Cell-based ELISA: Provides quantitative measurement of phosphorylation levels across multiple conditions

• Western blot analysis: Allows simultaneous assessment of multiple PRKD1 phosphorylation sites to understand the relationship between Tyr463 phosphorylation and other regulatory modifications

Readout considerations:

• Measure both Tyr463 phosphorylation and functional outcomes (e.g., NF-κB activation)

• Include assessment of downstream targets to confirm biological relevance of inhibition

• Consider isoform specificity by examining effects on PRKD1 vs. PRKD2/3